Medifoxamine

  • IUPAC: N, N -dimethyl- 2, 2 - diphenoxyethylamin
  • Latin: Medifoxaminum

N06AX13

Antidepressants

750 mg · kg -1 ( LD50, mouse, oral)

Template: Infobox chemical / molecular formula search available

Medifoxamin is a drug that was used prior to its withdrawal from the market for the treatment of depression. It acts as a dopamine reuptake inhibitor and as an agonist at the 5HT2A and 5HT2C receptor. The Merck daughter Lipha sales Medifoxamin as part of a drug under the trade name Cledial.

Medifoxamin was used mainly in France. 1999, it was taken off the market because rare but severe cases of liver damage have been reported.

CAS registry number PubChem Anatomical Therapeutic Chemical Classification System Active ingredient Major depressive disorder
561144
de